Elevance Health (NYSE:ELV) Upgraded to Buy at StockNews.com
Elevance Health (NYSE:ELV – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Thursday. Several other analysts have also issued reports on ELV. Cantor Fitzgerald reiterated an “overweight” rating and set a $485.00 price objective on shares of Elevance […]
